Page 331 - ATP-P 11th Ed
P. 331

Side-effects:
        •  Respiratory: laryngospasm, bronchospasm, wheezing, shallow respirations
        •  Cardiovascular: bradycardia, tachycardia
        •  Gastrointestinal: vomiting
        •  CNS/neuromuscular: retrograde amnesia, hallucination, confusion
        •  Special senses: blurred vision, diplopia, nystagmus, pinpoint pupils
        •  Hypersensitivity: anaphylactoid reactions, hives, rash, pruritus
        •  Miscellaneous: yawning, lethargy, chills, weakness
             K9 Dose: 0.3mg/kg plus 5mg/kg ketamine IV (for sedation) 0.3mg/kg IV (for seizures)
        Contraindications:
        •  Known sensitivity to midazolam
        •  Acute narrow angle glaucoma
        •  Injectable midazolam should not be administered to adult or pediatric patients in shock
          or coma, or in acute alcohol intoxication with depression of vital signs
        •  Concurrent use of protease inhibitors (anti-HIV)
        Pregnancy Category D
        •     Warnings:                                                       SECTION 3
          °    Use with caution when other medications capable of producing central nervous sys-
            tem depression are used.
          °    Prior  to  the  intravenous  administration  of  midazolam  be  sure  that  the  immediate
            availability of oxygen, resuscitative drugs, age and size-appropriate equipment for
            bag/valve/mask ventilation and intubation, and skilled personnel for the maintenance
            of a patent airway and support of ventilation are available.
          °    Monitor patients continuously for early signs of hypoventilation, airway obstruction,
            or apnea.
          °    Use with caution in patients with severe fluid or electrolyte disturbances.
          °   Oxygen is desirable, but not absolutely required.
        Overdose treatment:
        •  Flumazenil may be used to reverse the effects of midazolam after accidental over-
          administration. Flumazenil should not be used to reverse midazolam after seizure treat-
          ment since this may result in intractable seizures. It should also not be used in the setting
          of an intentional or mixed drug overdose.
        •  Monitor vital signs during the recovery period.
        TMEP use:
        •  Acute Behavioral Changes Protocol
        •  K9 Trauma Management Protocol
        •  K9 RDX (C-4) Ingestion Protocol
        •  Seizures Protocol
        •  TCCC/TTP


                                              ATP-P Handbook 11th Edition 321
   326   327   328   329   330   331   332   333   334   335   336